Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Issue of Equity

2 Mar 2022 16:58

RNS Number : 4384D
Amati AIM VCT PLC
02 March 2022
Β 

Amati AIM VCT plc

Β 

2 March 2022

Β 

Amati AIM VCT plcΒ (the "Company")

Β 

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Β 

Issue of Equity

Β 

The Board ofΒ Amati AIM VCT plcΒ (the "Company") is pleased to announce that onΒ 2 March 2022Β it allotted 11,429,326 new Ordinary Shares of 5p each in the capital of the Company ("Ordinary Shares") pursuant to the re-opening of the Offer for Subscription on 16 February 2022Β (the "Offer"). In accordance with the terms and conditions of the Offer, the price at which new Ordinary Shares were allotted, which was calculated by reference to the net asset value of an ordinary share on 28 February 2022, was 166.42p per Ordinary Share (net asset value divided by 0.99 to allow for issue costs of 1.0%).

Β 

As announced onΒ 21 February 2022, the Offer is fully subscribed and closed for further applications.

Β 

Applications have been made for the new Ordinary Shares to be admitted to the Official List of theΒ FCAΒ (with a Premium Listing) and to theΒ London Stock ExchangeΒ for admission to trading on the main market for listed securities. It is expected that admission will occur and dealing will commence in the new Ordinary Shares on or aroundΒ 10 March 2022.

Β 

As a result of the issue, the total number of Ordinary Shares in issue will be 147,999,507 and the total number of voting rights in the Company will be 147,999,507. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules.

Β 

For further information, please contact the investor line atΒ Amati Global InvestorsΒ on 0131 503 9115 or by email atΒ info@amatiglobal.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IOEBKBBPABKDQNK
Date   Source Headline
1st Apr 20207:53 amRNSTotal Voting Rights
31st Mar 202010:11 amRNSIssue of Equity
27th Mar 20205:26 pmRNSHolding(s) in Company
27th Mar 20205:26 pmRNSHolding(s) in Company
27th Mar 20204:49 pmRNSNet Asset Value(s)
27th Mar 20209:51 amRNSTransaction in Own Shares
26th Mar 20207:37 amRNSIssue of Equity - replacement
24th Mar 202010:48 amRNSIssue of Equity
23rd Mar 202011:42 amRNSNet Asset Value(s)
20th Mar 20203:37 pmRNSHolding(s) in Company
19th Mar 20207:39 amRNSIssue of Equity - replacement
18th Mar 202012:32 pmRNSDirector/PDMR Shareholding
18th Mar 202012:29 pmRNSIssue of Equity
16th Mar 20203:15 pmRNSNet Asset Value(s)
16th Mar 202012:49 pmRNSTransaction in Own Shares
12th Mar 20204:14 pmRNSTransaction in Own Shares
12th Mar 202011:06 amRNSTransaction in Own Shares
10th Mar 20202:55 pmRNSTransaction in Own Shares
6th Mar 20203:43 pmRNSNet Asset Value(s)
6th Mar 202012:30 pmRNSTransaction in Own Shares
3rd Mar 20205:01 pmRNSDirector/PDMR Shareholding
3rd Mar 20204:17 pmRNSIssue of Equity
3rd Mar 20209:38 amRNSNet Asset Value(s)
2nd Mar 20208:30 amRNSTotal Voting Rights
25th Feb 202012:17 pmRNSTransaction in Own Shares
24th Feb 202012:06 pmRNSTransaction in Own Shares
24th Feb 202010:03 amRNSNet Asset Value(s)
21st Feb 20203:14 pmRNSTransaction in Own Shares
14th Feb 20204:37 pmRNSNet Asset Value(s)
11th Feb 20205:29 pmRNSDirector/PDMR Shareholding
11th Feb 20205:05 pmRNSReplacement Transaction in Own Shares
11th Feb 20204:53 pmRNSIssue of Equity
11th Feb 20203:40 pmRNSTransaction in Own Shares
10th Feb 20203:20 pmRNSTransaction in Own Shares
7th Feb 20204:31 pmRNSNet Asset Value(s)
7th Feb 202011:58 amRNSTransaction in Own Shares
4th Feb 20209:42 amRNSNet Asset Value(s)
3rd Feb 202012:33 pmRNSTransaction in Own Shares
3rd Feb 202010:34 amRNSTotal Voting Rights
27th Jan 20202:43 pmRNSHolding(s) in Company
24th Jan 20204:20 pmRNSNet Asset Value(s)
23rd Jan 20202:17 pmRNSTransaction in Own Shares
22nd Jan 202012:35 pmRNSTransaction in Own Shares
20th Jan 202010:12 amRNSNet Asset Value(s)
17th Jan 20203:32 pmRNSHolding(s) in Company
17th Jan 202011:56 amRNSDirector Declaration
14th Jan 20202:22 pmRNSTransaction in Own Shares
14th Jan 202010:40 amRNSIssue of Equity
10th Jan 20204:11 pmRNSNet Asset Value(s)
8th Jan 20204:13 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.